Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey ; volume:38 ; number:9 ; day:4 ; month:4 ; year:2023 ; pages:3035-3042 ; date:9.2023
Pediatric nephrology ; 38, Heft 9 (4.4.2023), 3035-3042, 9.2023
- Urheber
-
Zurowska, Aleksandra
Drozynska-Duklas, Magdalena
Topaloglu, Rezan
Bouts, Antonia
Boyer, Olivia
Shenoy, Mohan
Vivarelli, Marina
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00467-023-05913-1
- URN
-
urn:nbn:de:101:1-2023110413050000645322
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zurowska, Aleksandra
- Drozynska-Duklas, Magdalena
- Topaloglu, Rezan
- Bouts, Antonia
- Boyer, Olivia
- Shenoy, Mohan
- Vivarelli, Marina
- SpringerLink (Online service)
Ähnliche Objekte (12)
Rituximab for nephrotic syndrome in children
Hypokalemia after rituximab administration in nephrotic syndrome: two case reports
Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials
The glomerular permeability factors in idiopathic nephrotic syndrome
Childhood idiopathic nephrotic syndrome: recent advancements shaping future guidelines
Best practice guidelines for idiopathic nephrotic syndrome: recommendations versus reality
The role of the immune system in idiopathic nephrotic syndrome
Rituximab is not a “magic drug” in post-transplant recurrence of nephrotic syndrome
A prospective cohort study of rituximab in the treatment of refractory nephrotic syndrome
Congenital nephrotic syndrome
Endothelin 1 and endothelial dysfunction in children with idiopathic nephrotic syndrome
The efficacy and safety of rituximab in treating childhood nephrotic syndrome: an Italian perspective
Rituximab for nephrotic syndrome in children
Hypokalemia after rituximab administration in nephrotic syndrome: two case reports
Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials
The glomerular permeability factors in idiopathic nephrotic syndrome
Childhood idiopathic nephrotic syndrome: recent advancements shaping future guidelines
Best practice guidelines for idiopathic nephrotic syndrome: recommendations versus reality
The role of the immune system in idiopathic nephrotic syndrome
Rituximab is not a “magic drug” in post-transplant recurrence of nephrotic syndrome
A prospective cohort study of rituximab in the treatment of refractory nephrotic syndrome
Congenital nephrotic syndrome
Endothelin 1 and endothelial dysfunction in children with idiopathic nephrotic syndrome
The efficacy and safety of rituximab in treating childhood nephrotic syndrome: an Italian perspective
Rituximab for nephrotic syndrome in children
Hypokalemia after rituximab administration in nephrotic syndrome: two case reports
Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials
The glomerular permeability factors in idiopathic nephrotic syndrome
Childhood idiopathic nephrotic syndrome: recent advancements shaping future guidelines
Best practice guidelines for idiopathic nephrotic syndrome: recommendations versus reality
The role of the immune system in idiopathic nephrotic syndrome
Rituximab is not a “magic drug” in post-transplant recurrence of nephrotic syndrome
A prospective cohort study of rituximab in the treatment of refractory nephrotic syndrome
Congenital nephrotic syndrome
Endothelin 1 and endothelial dysfunction in children with idiopathic nephrotic syndrome